Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience
Roberto Scicali, Antonino Di Pino, Francesca Urbano, Viviana Ferrara, Simona Marchisello, Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Agata Maria Rabuazzo, Francesco Purrello, Salvatore Piro
Topics & Concepts
SteatosisInternal medicineMedicineEzetimibePCSK9GastroenterologyTriglycerideNonalcoholic fatty liver diseasePopulationFatty liverEndocrinologyKexinCholesterolDiseaseLipoproteinLDL receptorEnvironmental healthLipoproteins and Cardiovascular HealthLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins